$0.6400
-0.0049-0.76%
Calidi Biotherapeutics Inc
CLDIAMEX
Calidi Biotherapeutics (CLDI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | — | $-24.96 | $-26.88 |
| Actual | $-2.94 | $-6.88 | $-9.12 | $-35.36 |
| Surprise | — | — | +63.5% | -31.6% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | Mar 27, 2026 | $-9.12 | $-24.96 | 63.5 % |
| Q3 | Nov 13, 2025 | $-35.36 | $-26.88 | -31.6 % |
| Q2 | Aug 8, 2025 | $-31.84 | $-21.12 | -50.8 % |
| Q3 | Nov 12, 2024 | $-124.80 | $-163.20 | 23.5 % |
